Arcus Foundation
Non-Profit & Charitable Organizations · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
44 W 28th St Fl 17, New York City, New Y...Phone Number
(212) 488-3000Website
www.arcusfoundation.orgRevenue
$12.3 MillionIndustry
About Arcus Foundation
Arcus Foundation Org Chart
Is Arcus Foundation your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Arcus Foundation had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Arcus Foundation
Arcus Foundation, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Arcus Foundation is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Arcus Foundation recently announced quarterly report
Product Launch: Get notified when Arcus Foundation launches new products
Check if Arcus Foundation has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Arcus Foundation has new funding data
Recommended Actions
Reach out to Masked Content who joined Arcus Foundation as Masked Content
Find 2 more new buyers
Compare Similar Companies to Arcus Foundation
Compare insights from companies similar to Arcus Foundation, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Arcus Foundation is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Arcus Foundation is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Arcus Foundation.
Arcus Foundation Tech Stack
A closer look at the technologies used by Arcus Foundation
Most Recent Scoops
Arcus Foundation News & Media
Arcus Biosciences Announces New Employment Inducement Grants
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted eight new employees options to purchase a total of 31,600 shares of the Company’s common stock at an exercise price per share of $20.68, which was the closing price on February 8, 2023, anArcus Biosciences to Participate at Upcoming Virtual Investor Events
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate at the following upcoming February 2023 virtual investor events: SVB Securities Virtual Global Biopharma Conference Date: Tuesday, February 14th, 2023 Time: 12:00 p.m. ET Format: Fireside Chat Citi’s 2023 Virtual Oncology Leadership SArcus Biosciences Announces New Employment Inducement Grants
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensation Committee of the Company’s Board of Directors granted ten new employees options to purchase a total of 44,300 shares of the Company’s common stock at an exercise price per share of $22.02, which was the closing price on January 23, 2023, and restricted stock units to acquire a total of 22,150Arcus Biosciences Announces New Employment Inducement Grants
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensation Committee of the Company’s Board of Directors granted one new employee options to purchase a total of 1,450 shares of the Company’s common stock at an exercise price per share of $17.51, which was the closing price on January 9, 2023, and restricted stock units to acquire a total of 725 shares
Top Non-Profit & Charitable Organizations Companies
Frequently Asked Questions Regarding Arcus Foundation
Founded in 2000 by Jon Stryker, the Arcus Foundation is a private grantmaking institution dedicated to the idea that people can live in harmony with one another and the natural world. Arcus' work is based on the belief that respect for diversity among peoples and in nature is essential to a positive future for our planet and all of its inhabitants.... Read More